Finanzwire Finanzwire
Basculer en Français
11289 Companies
250843 Keywords
179648 Articles
136680 Press releases
Headlines Articles Press releases Relief Therapeutics Holdings AG Remove
  1. Home
  2. Companies
  3. Relief Therapeutics Holdings AG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 02/28/2023 at 07:00, 3 years 8 months ago

    Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars

    Logo of Relief Therapeutics Holdings AG
  • PRESS RELEASE

    published on 02/14/2023 at 07:00, 3 years 8 months ago

    Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa

    Logo of Relief Therapeutics Holdings AG
  • PRESS RELEASE

    published on 02/08/2023 at 07:00, 3 years 8 months ago

    Relief Therapeutics Provides an Update on its Financing Strategy

    Logo of Relief Therapeutics Holdings AG
  • PRESS RELEASE

    published on 01/17/2023 at 06:56, 3 years 9 months ago

    Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom

    Logo of Relief Therapeutics Holdings AG
Previous page
1 ... 5 6
Accesswire
  • Published on 11/06/2026 at 01:20, 48 minutes ago

    Presentation to Munich Mining Conference

  • Published on 11/06/2026 at 00:53, 1 hour 15 minutes ago

    Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution

  • Published on 11/06/2026 at 00:45, 1 hour 23 minutes ago

    Gabriel Announces Closure of ICSID Annulment Proceedings

  • Published on 11/05/2026 at 23:20, 2 hours 48 minutes ago

    Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines

  • Published on 11/05/2026 at 22:05, 4 hours 3 minutes ago

    Innodata Reports Record Third Quarter 2026 Results

View all ACCESSWIRE
EQS Group
  • Published on 11/06/2026 at 00:05, 2 hours 3 minutes ago

    RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period

  • Published on 11/05/2026 at 22:05, 4 hours 3 minutes ago

    Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook

  • Published on 11/05/2026 at 20:38, 5 hours 30 minutes ago

    freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback

  • Published on 11/05/2026 at 20:37, 5 hours 31 minutes ago

    EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million

  • Published on 11/05/2026 at 19:45, 6 hours 22 minutes ago

    Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets

View all EQS
Les Echos
  • Published on 11/05/2026 at 18:21, 7 hours 46 minutes ago

    Total number of voting rights and shares making up the share capital at October 31, 2026

  • Published on 11/05/2026 at 17:50, 8 hours 18 minutes ago

    NRJ GROUP - Financial information Q3 2026

  • Published on 11/05/2026 at 17:45, 8 hours 23 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 11/05/2026 at 17:29, 8 hours 39 minutes ago

    Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082

  • Published on 11/05/2026 at 10:16, 15 hours 52 minutes ago

    Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy